Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 3, 2012, Pages 632-640

  Frydrychowicz, Alex ^a,b   Jedynak, Andrzej R ^b   Kelcz, Frederick ^b   Nagle, Scott K ^b   Reeder, Scott B ^b,c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

gadoxetic acid; hepatobiliary contrast enhancement; magnetic resonance cholangiography; primary sclerosing cholangitis; T1 weighted MR cholangiography; T2 weighted MR cholangiopancreaticography

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CHOLANGIOGRAPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATICOGRAPHY; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; IMAGE QUALITY; LIVER FUNCTION TEST; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCORING SYSTEM; THREE DIMENSIONAL IMAGING; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLANGITIS, SCLEROSING; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84865346377     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23683     Document Type: Article

References (26)

1. Chapman RW,. Aetiology and natural history of primary sclerosing cholangitis-a decade of progress? Gut 1991; 32: 1433-1435.
2. Lee YM, Kaplan MM,. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-933.
3. Levy C, Lindor KD,. Primary sclerosing cholangitis: epidemiology, natural history, and prognosis. Semin Liver Dis 2006; 26: 22-30. (Pubitemid 43320724)
4. Vitellas KM, El-Dieb A, Vaswani KK, et al. MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography. AJR Am J Roentgenol 2002; 179: 399-407. (Pubitemid 34785643)
5. Dave M, Elmunzer BJ, Dwamena BA, Higgins PD,. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010; 256: 387-396.
6. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC,. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992; 27: 612-619.
7. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U,. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: 59-64.
8. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ,. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 1997; 7: 126-132. (Pubitemid 127538537)
9. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-792.
10. Ringe KI, Husarik DB, Gupta RT, Boll DT, Merkle EM,. Hepatobiliary transit times of gadoxetate disodium (Primovist((R))) for protocol optimization of comprehensive MR imaging of the biliary system-What is normal? Eur J Radiol 2011; 79: 201-205.
11. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199: 177-183. (Pubitemid 26098637)
12. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237: 89-98. (Pubitemid 41346150)
13. Dahlstrom N, Persson A, Albiin N, Smedby O, Brismar TB,. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 2007; 48: 362-368. (Pubitemid 46633865)
14. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D,. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008; 18: 1577-1586.
15. Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009; 29: 1707-1724.
16. Lee MS, Lee JY, Kim SH, et al. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: Comparison with gadobenate dimeglumine-enhanced MRI. J Magn Reson Imaging 2011; 33: 149-159.
17. Brittain JH, Hu BS, Wright GA, Meyer CH, Macovski A, Nishimura DG,. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med 1995; 33: 689-696.
18. Busse RF, Brittain JH, Reeder SB, Kelcz F,. Improved background suppression for 3D-MRCP using T2-Prep. Proc Int Soc Magn Reson Med 2006; 14: 392.
19. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212: 876-884. (Pubitemid 29410996)
20. Nagle SN, Busse RF, Brau AC, et al. High-Resolution Free-Breathing 3D T1 Weighted Hepatobiliary Imaging Optimized for Gd-EOB-DTPA. In: Proceedings of the 18th Annual Meeting of ISMRM, Honolulu, Hawaii, 2009. (abstract 2076).
21. Bashir MR, Merkle EM,. Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol 2010; 21: 291-294.
22. Frydrychowicz A, Nagle SK, D'souza SL, Vigen KK, Reeder SB,. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: A cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 2011 [Epub ahead of print].
23. Brau AC, Beatty PJ, Skare S, Bammer R,. Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods. Magn Reson Med 2008; 59: 382-395. (Pubitemid 351220102)
24. Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N,. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 2009; 50: 709-715.
25. Motosugi U, Ichikawa T, Sano K, et al. Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 2010; 46: 141-145.
26. Feuerlein S, Boll DT, Gupta RT, Ringe KI, Marin D, Merkle EM,. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. AJR Am J Roentgenol 2011; 196: W18-W24.